EurekaMag.com logo
+ Site Statistics
References:
47,893,527
Abstracts:
28,296,643
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The prevalence of cytomegalovirus complement fixing antibodies in the turkish population






Mikrobiyoloji Bulteni 14(1): 47-52

The prevalence of cytomegalovirus complement fixing antibodies in the turkish population

The prevalence of cytomegalovirus antibodies in the Turkish population was studied by complement fixation in 692 sera obtained from various age groups. Antibody titers of 1:8 or higher were detected in 68% of 0-5 yr olds and in 93% of those aged 55 and above. Cytomegalovirus infections are frequent and recurrent in Turkish communities, as they are in other countries which have low living and socio-economic standards.


Accession: 006740295



Related references

Alaçam, R., 1980: A study on the prevalence of cytomegalovirus complement-fixing antibodies in the Turkish population. The prevalence of cytomegalovirus (Ad 169) antibodies in the Turkish population is studied by complement fixation techniques in 692 sera obtained from various age groups. The titer of 1:8 or higher antibody levels detected in 68% of 0-5 age groups...

Monif, G.R.; Hildebrandt, R.J.; Weber, J.M., 1970: Prevalence of complement-fixing antibodies to cytomegalovirus in a semirural southern county. American Journal of Obstetrics and Gynecology 108(3): 372-374

Seeman, J., 1976: Immunological study of cytomegalovirus complement-fixing antibodies in the population of the CSR. The population from different regions of the CSR was examined serologically for the presence of cytomegalovirus (CMV) antibodies. Exclusively persons showing no signs of disease, chosen by random selection, were examined. The immunological survey...

Seeman J., 1976: Immunological study of cytomegalovirus complement fixing antibodies in the population of czechoslovakia. Journal of Hygiene Epidemiology Microbiology & Immunology (Prague) 20(4): 489-496

Bergaminl F.M.S.inazzola; Castagna, P.C., 1967: Behavior of antibodies fixing the complement by cytomegalovirus in a healthy Milan population under 15 years old. The results of a serological survey carried out in Milan on 304 subjects from 0 to 15 years of age, in order to test the diffusion of Cytomegalovirus infection, by assaying the c.f [complement fixing] antibodies, are reported. The cf antigen was p...

Cour M.I.; Ortega P.; Artieda P.; Gimenez M.; Hervas M.C., 1985: Mycoplasma pneumoniae prevalence of complement fixing antibodies in an urban population. Complement fixing antibodies against M. pneumoniae were determined in 569 samples from a control group (age range 6 mo.-90 yr) drawn from the urban population of Madrid [Spain]. Antibodies were detected in 81%, with high titers found in 14.24%. Th...

Váczi, L.; Gönczöl, E.; Lehel, F.; Géder, L., 1965: Isolation of cytomegalovirus and incidence of complement-fixing antibodies against cytomegalovirus in different age-groups. In infants suffering from cytomegalic inclusion disease or from interstitial pneumonia CMV has been isolated. In spite of negative serology, the typical clinical picture and the successful isolations suggested the possible aetiologic role of the i...

Andersen, H.K., 1969: Complement-fixing and neutralizing antibodies against cytomegalovirus strain AD 169 in sera from infants with cytomegalovirus infection. Scandinavian Journal of Infectious Diseases 1(3): 141-144

Spencer E.S.; Andersen H.K., 1972: The development of immuno fluorescent antibodies as compared with complement fixing antibodies and virus neutralizing antibodies in human cytomegalovirus infection. Scandinavian Journal of Infectious Diseases 4(2): 109-112

Spencer, E.S.; Andersen, H.K., 1972: The development of immunofluorescent antibodies as compared with complement-fixing and virus-neutralizing antibodies in human cytomegalovirus infection. Scandinavian Journal of Infectious Diseases 4(2): 109-112